Universe Pharmaceuticals (UPC) Invested Capital (2020 - 2025)
Historic Invested Capital for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $56576.1 billion.
- Universe Pharmaceuticals' Invested Capital rose 796.23% to $56576.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $56576.1 billion, marking a year-over-year increase of 796.23%. This contributed to the annual value of $56576.1 billion for FY2025, which is 796.23% up from last year.
- As of Q3 2025, Universe Pharmaceuticals' Invested Capital stood at $56576.1 billion, which was up 796.23% from $52403.5 billion recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Invested Capital registered a high of $56576.1 billion during Q3 2025, and its lowest value of $32.3 million during Q1 2024.
- For the 5-year period, Universe Pharmaceuticals' Invested Capital averaged around $13630.4 billion, with its median value being $14.0 billion (2022).
- Its Invested Capital has fluctuated over the past 5 years, first crashed by 9999.51% in 2021, then soared by 18721844.39% in 2024.
- Universe Pharmaceuticals' Invested Capital (Quarter) stood at $47.0 million in 2021, then soared by 75059.29% to $35.3 billion in 2022, then dropped by 20.82% to $28.0 billion in 2023, then surged by 187218.44% to $52403.5 billion in 2024, then increased by 7.96% to $56576.1 billion in 2025.
- Its Invested Capital was $56576.1 billion in Q3 2025, compared to $52403.5 billion in Q3 2024 and $32.3 million in Q1 2024.